NASCI 2024 just concluded, showing how the integration of real-world data, including imaging data, is essential for driving innovation in cardiovascular research. Our fit-for-purpose regulatory grade real-world imaging datasets (RWiD) and multimodal longitudinal datasets are tailored to meet the needs of pharmaceutical and biotech companies. These datasets have been instrumental in planning and optimizing clinical trials, ensuring the recruitment of suitable patients.
